Posts

Showing posts with the label Influenza Diagnostics Market Size

Influenza Diagnostics Market To Witness A Significant Growth Of USD 1.46 Billion By 2030

  San Francisco, 13 Dec 2023:  The Report  Influenza Diagnostics Market  Size, Share & Trends Analysis Report By Test Type (RIDT, RT-PCR, Cell Culture), By End Use (Hospitals, Laboratories, POCT), By Region, And Segment Forecasts, 2023 - 2030 The global influenza diagnostics market size is expected to reach USD 1.46 billion by 2030, registering a CAGR of 3.6% from 2023 to 2030, according to a new report by Grand View Research, Inc. The increasing surveillance of the infection and the rising prevalence of chronic diseases around the world are contributing to the demand for influenza diagnostics. For instance, in September 2022, National Influenza Centres and other laboratories from 102 countries tested over 112,017 specimens between 22 August 2022 to 04 September 2022. Out of those, 3,879 tested positive for influenza viruses. The increasing involvement of international organizations and regulations, such as WHO and the U.S. Department of Health & Human Services to control the s

Influenza Diagnostics Market Size Is Anticipated To Reach USD 3.3 Billion By 2024 : Grand View Research Inc.

San Francisco, 20 June 2019:   The Report  Influenza Diagnostics Market   Size, Share & Trends Analysis Report By Test Type (RIDT, RT-PCR, Cell Culture), By End-use (Hospitals, Laboratories, POCT), By Region, And Segment Forecasts, 2018 – 2024 The influenza diagnostics market is expected to reach USD 3.3 billion by 2024, according to a new report by Grand View Research, Inc. Influenza, or "the flu," is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on public health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. The growth in the influenza diagnostic market is attributed to factors such as emergence of technologically advanced diagnostic tests with shorter turnaround time; initiatives by regulatory bodies, such as CDC’s seasonal influenz